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Abstract
Identifying differentially expressed (DE) genes associated with a sample char-
acteristic is the primary objective of many microarray studies. As more and more
studies are carried out with observational rather than well controlled experimen-
tal samples, it becomes important to evaluate and properly control the impact of
sample heterogeneity on DE gene finding. Typical methods for identifying DE
genes require ranking all the genes according to a pre-selected statistic based on
a single model for two or more group comparisons, with or without adjustment
for other covariates. Such single model approaches unavoidably result in model
misspecification, which can lead to increased error due to bias for some genes and
reduced efficiency for the others. We evaluated the impact of model misspeci-
fication from such approaches on detecting DE genes and identified parameters
that affect the magnitude of impact. To properly control for sample heterogeneity
and to provide a flexible and coherent framework for identifying simultaneously
DE genes associated with a single or multiple sample characteristics and/or their
interactions, we proposed a Bayesian model averaging approach which corrects
the model misspecification by averaging over model space formed by all relevant
covariates. An empirical approach is suggested for specifying prior model prob-
abilities. We demonstrated through simulated microarray data that this approach
resulted in improved performance in DE gene identification compared to the sin-
gle model approaches. The flexibility of this approach is demonstrated through
our analysis of data from two observational microarray studies.
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Abstract
Identifying differentially expressed (DE) genes associated with a sample characteristic is the pri-
mary objective of many microarray studies. As more and more studies are carried out with observational
rather than well controlled experimental samples, it becomes important to evaluate and properly control
the impact of sample heterogeneity on DE gene finding. Typical methods for identifying DE genes re-
quire ranking all the genes according to a pre-selected statistic based on a single model for two or more
group comparisons, with or without adjustment for other covariates. Such single model approaches un-
avoidably result in model misspecification, which can lead to increased error due to bias for some genes
and reduced efficiency for the others. We evaluated the impact of model misspecification from such
approaches on detecting DE genes and identified parameters that affect the magnitude of impact. To
properly control for sample heterogeneity and to provide a flexible and coherent framework for identi-
fying simultaneously DE genes associated with a single or multiple sample characteristics and/or their
interactions, we proposed a Bayesian model averaging approach which corrects the model misspeci-
fication by averaging over model space formed by all relevant covariates. An empirical approach is
suggested for specifying prior model probabilities. We demonstrated through simulated microarray data
that this approach resulted in improved performance in DE gene identification compared to the single
model approaches. The flexibility of this approach is demonstrated through our analysis of data from
two observational microarray studies.
Keywords: Bayesian model averaging; differential gene expression; microarray; observational study.
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1 Introduction
In recent years, as the rapid advances in biotechnology have markedly driven down the cost of microarray
experiments, more and more large scale studies are carried out with heterogeneous samples conveniently
collected from subjects of different phenotypic characteristics and exposure histories. Such microarray
studies are considered observational rather than experimental in nature (Potter, 2003) because the effects
of confounding or correlation in covariates need to be properly handled. The sample complexity of such
studies presents both opportunities and challenges to the analysis. Considering the differential gene expres-
sion studies, with multifaceted sample characteristics, one may explore more complex questions that are
not possible with a more homogeneous sample. It should be possible, for example, to identify differentially
expressed (DE) genes associated with not just one sample characteristic but multiple characteristics and/or
their interactions. However, the existing methodologies are not adequate to address those questions. For
example, in a recent study by Boyle et al. (2010) to evaluate the effects of smoking on the transcriptome of
human oral mucosa, besides the standard question of identifying genes affected by smoking among all sub-
jects, the investigators were also interested in identifying genes that may be affected by smoking differently
between males and females. In another study involving smokers and never smokers (Carolan et al., 2008),
micorarray data were obtained for an unbalanced lung airway epithelium sample involving different tissue
sites from subjects of different gender, age and ethnicity. An interesting question is to identify DE genes
associated with either a single or multiple sample characteristics. Direct application of current available
approaches to these questions does not provide a coherent solution and has clear limitations.
Methods for identifying DE genes are typically based on the ranking of statistics for between group
differences associated with one sample characteristic (also known as a factor or a covariate), such as the
t-, F- statistics, their non-parametric counterparts, their modified forms, or the Bayesian versions (see Jef-
fery et al. (2006) for a review of the various approaches). These methods are suited for well controlled
experiments. Their lack of control for confounding factors attracts increasing concern when applied to
observational microarray studies (Potter, 2003; Webb et al., 2007; Troester et al., 2009). Indeed, with ob-
servational samples, the results may be confounded by a variety of sample characteristics, such as age, sex,
genetic profile, exposure and treatment history, etc. This confounding effect can lead to an increased num-
ber of false discoveries. Recent studies by Scheid and Spang (2007) and Leek and Storey (2007) suggested
that hidden traces of unknown confounders may exist in DE gene studies and that ranking statistics need
to be adjusted accordingly. To account for the effects of possible confounders, several approaches have
been adapted from traditional observational studies and applied to microarray data (Smyth, 2004; Hummel
et al., 2008). These approaches deal with possible confounding either through multiple regression analysis
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that adjusts for known confounders or unrecorded confounders represented by surrogate variables (Leek and
Storey, 2007) or through a matched study design (Heller et al., 2009).
Regardless of covariate adjustment, the aforementioned approaches rank the genes based on the effect
sizes estimated using the same model for all genes. Such a single model approach can be problematic for
high dimensional microarray data because different genes may be involved in different biological processes
and their expression may be affected by different sets of covariates. More specifically, such an approach
leads to model misspecification for a certain proportion of the genes and does not offer the same level of
accuracy and efficiency for the effect size estimation for genes under investigation.
To avoid model misspecification in microarray data analysis, an ideal solution could be to apply different
models to different sets of genes whereby each model contains only the set of covariates relevant to the genes
it is describing. Yet, identifying appropriate models for different sets of genes can be challenging since
model uncertainties make it difficult to identify a single best model. Bayesian model averaging (BMA)
approach offers an attractive alternative solution to this problem. Hoeting et al. (1999) provides a review of
this approach in more traditional settings. In recent years, BMA approaches have been developed to handle
various problems involving high throughput genetic data. For example, Yeung et al. (2005) developed a
BMA approach for improved sample classification using microarray data. Xu et al. (2011) and Wu et al.
(2010) developed BMA approaches for the gene association studies. Sebastiani et al. (2006) developed a
BMA approach for differential gene expression analysis under two different distributional assumptions of
the data. Ishwaran and Rao (2003) and Conlon et al. (2006) developed Bayesian model selection/averaging
approaches for differential gene expression analysis under ANOVA-based models. All these approaches are
computationally expensive as MCMC simulation are needed to obtain estimates of model parameters. In this
study, we propose a BMA approach for observational microarray studies based on linear regression models.
It does not require MCMC simulations for estimating model parameters and offers a flexible and coherent
framework to identify simultaneously DE genes associated with a single factor, multiple factors and/or their
interactions.
In the next section, we discuss the limitations of the single model approaches. In particular, we evaluate
the impact of model misspecification from such approaches on DE gene finding. We also identify parameters
that affect the magnitude of impact. In Section 3, a BMA approach to DE gene finding is proposed. This
approach intends to properly control for sample heterogeneity and to account for model uncertainty. In
section 4, we compared the performances of ranking statistics based on a simple model, a complex model
and the BMA approach in simulated microarray studies. Finally, in section 5, the BMA approach was
applied to two existing microarray data sets. Our analysis supports the utility of the BMA method as a
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robust and general tool for detecting DE genes in observational microarray studies.
2 Limitation of the Single Model Approaches
In this section, we consider a general framework to describe gene expression variations in microarrays.
Under this framework, we argue that the single model approaches to DE gene detection, are overly simplified
and subjected to the impact of model misspecification. For example, they can result in the following two
forms of model misspecification: (a) the omission of relevant covariates when a simple model is used, and
(b) the inclusion of irrelevant covariates when a complex model is used. The consequences of these two
forms of model misspecification have been discussed extensively in the linear regression setting (Rao, 1971,
1973; Rosenberg and Levy, 1972). The implication of these results, however, has not been fully investigated
in DE gene studies. In this section, we evaluate the consequences of model misspecification from the single
model approaches on performance measures often used in DE gene studies, including the false discovery
rate (FDR) and sensitivity. We conclude this section with a summary of the main results.
2.1 Notation
We consider an observational microarray study which aims to identify DE genes associated with different
values of a factor X1, for example, cigarette smoking exposure. Expression profiles of J genes are obtained
for n subjects with different values of X1. Without loss of generality, a typical model for identifying X1
related DE genes can be written as:
yij = β0j + β1jx1i + · · ·+ βkjxki + ηij (2.1)
or
yij = α0j + α1jx1i + · · ·+ αkjxki + α(k+1)jx(k+1)i + ǫij (2.2)
where yij is the normalized and typically log-transformed expression level of gene j in subject i, x1i is
the factor level for X1 in subject i, x2i, . . . , xki are factor levels for other factors, denoted by X2, . . . , Xk,
that affect the expression of all the genes, for example, experimental parameters involved in the microarray
experiments, and x(k+1)i is the level of a potential confounding factor , Xk+1, for example, gender, age,
race, alcohol exposure, etc. And ηij , ǫij denote normally distributed random errors.
To identify DE genes related to X1, p-values based on t-statistic of estimate of either β1j or α1j can
be used as the ranking statistics. If model (2.1) is used, the relevant t-statistic for gene j is tM1,1j =
βˆ1j/sd(βˆ1j), where βˆ1j is the least square estimate of β1j . If model (2.2) is used, the t-statistic for gene j is
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calculated as tM2,1j = αˆ1j/sd(αˆ1j). It can be shown that the two statistics are related as follows
tM1,1j =
S1·23...k
S1·23...k+1
tM2,1j +
S−2k+1·1...kbk+1,1e
T
k+1Yj
sd(βˆ1j)
. (2.3)
where S2k+1·1...k, bk+1 and ek+1 are the residual sum of squares, least square parameter estimates and resid-
ual, respectively, from the following auxiliary regression equation
Xk+1 = Xbk+1 + ek+1 (2.4)
where X = (X1, . . . , Xk). And S21·23...k.k+1 is the residual sum of squares for the auxiliary regression with
X1 as the outcome and X2, . . . , Xk+1 as the covariates.
For an observational microarray study, such single model approach with or without covariate adjustment
has an intrinsic limitation which is that neither model can be the true model for all the genes. For the above
discussed hypothetical microarray study, model (2.1) is the true model only for genes not related to Xk+1
(Xk+1 null genes, or M1 genes), and model (2.2) is the true model only for genes related to Xk+1 (Xk+1
DE genes, or M2 genes). Based on these considerations, a multi-model approach that uses p-values of tM1,1·
to rank the M1 genes and p-values of tM2,1· to rank the M2 genes is preferable.
The performance difference between the single model and the multi-model approaches can be compared
by utilizing the relationship between the two t-statistics. Let F1(t) and F2(t) be the density distributions of
the ranking statistics tM1,1· and tM2,1·, respectively. Under the multi-model approach, the density distribu-
tion of the ranking statistics can be written as
F (t) = (1− f)F1(t) + fF2(t)
where f is the proportion of M2 genes. F1(t) and F2(t) can further be written as
F1(t) = (1− p1)F10(t) + p1F11(t)
F2(t) = (1− p2)F20(t) + p2F21(t).
where p1 and p2 are the proportions of DE genes in M1 and M2 genes, F·0(t) and F·1(t) are distributions of
the test statistic for the null and DE genes, respectively. For a given cut-off c > 0, the false discovery rate
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and sensitivity can be calculated as
FDR(c) = (1−f)(1−p1)[1−F10(c)](1−f)[1−F1(c)]+f [1−F2(c)] +
f(1−p2)[1−F20(c)]
(1−f)[1−F1(c)]+f [1−F2(c)]
(2.5)
and
S(c) = 2(1− f)p1[1− F11(c)] + 2fp2[1− F21(c)].
We discuss the impact of the two single model approaches on the FDR and sensitivity separately.
2.2 Single model without covariate adjustment
When Model (2.1) is used, the FDR can be written as
FDRM1(c) = (1−f)(1−p1)[1−F10(c)]
(1−f)[1−F1(c)]+f [1−F
M1
2
(c)]
+
f(1−p2)[1−F
M1
20
(c)]
(1−f)[1−F1(c)]+f [1−F
M1
2
(c)]
The sensitivity can be written as
SM1(c) = 2(1− f)p1[1− F11(c)] + 2fp2[1− F
M1
21 (c)].
The superscript M1 is used to denote that the distribution of t-statistic is derived from model (2.1), which is
mis-specified for the M2 genes because of omitting relevant covariate Xk+1.
Omission of relevant covariate leads to bias in the model parameter estimates (Rao, 1971). Specifically,
the bias can be written as
Bias(βˆ1j) = E(S−2k+1·1...kbk+1,1e
T
k+1Yj) = αk+1,j · bk+1,1, (2.6)
where bk+1,1.23...k is the least square estimate of the parameter associated with X1 in the auxiliary regression
(2.4). Therefore, we have for the M2 gene j
E(tM1,1j) ≈
S1·23...k
S1·23...k+1
[
E(tM2,1j) +
bk+1,1αk+1
σ2j/S1·23...k+1
]
.
It is also known that S21·23...k.k+1 ≤ S21·23...k.
Therefore, for the M2 DE genes, because tM1,1j can be greater or less than tM2,1j depending on the
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values of α1 and Bias(βˆ1), FM121 (t) is unlikely to be systematically different from F21(t) and results in
great changes in sensitivity.
However, for the M2 null genes, the above results indicate E|tM1,1j | ≥ E|tM2,1j |, i.e. the distribution
of tM2,1j for the M2 null genes moves away from zero. Hence, 1 − F
M1
20 (c) ≥ 1 − F20(c). Let a and b be
the denominator and numerator of FDR(c) as written in (2.5), respectively. Let δ be the difference between
the numerators of FDRM1(c) and FDR(c), i.e.,
δ = f(1− p2){[1− F
M1
20 (c)]− [1− F20(c)]},
and δ′ be the difference between the denominators of the two FDRs
δ′ = f(1− p2){[1− F
M1
20 (c)]− [1− F20(c)]}+
fp2{[1− F
M1
21 (c)]− [1− F21(c)]}
.
As discussed above, [1 − FM121 (c)] is comparable to [1 − F21(c)] because the bias is unlikely to lead to
systematic difference between FM121 (t) and F21(t). Additionally, p2 generally is much smaller than 1 − p2
in microarrays. Therefore, δ′ ≈ δ and FDRM1(c) can be approximated by (b + δ)/(a + δ). Since (b +
δ)/(a+ δ) ≥ b/a for any a > b > 0 and δ ≥ 0, this indicates FDRM1(c) ≥ FDR(c), i.e., increased FDR
with this single model approach.
2.3 Single model with covariate adjustment
When Model (2.2) is used, the false discovery rate and sensitivity at a given cut-off can be written as
FDRM2(c) =
(1−f)(1−p1)[1−F
M2
10
(c)]
(1−f)[1−F
M2
1
(c)]+f [1−F2(c)]
+
f(1−p2)[1−F20(c)]
(1−f)[1−F
M2
1
(c)]+f [1−F2(c)]
and
SM2(c) = 2(1− f)p1[1− F
M2
11 (c)] + 2fp2[1− F21(c)]
due to the potential change in the distributions of test statistic for the M1 genes. And the relationship of the
two t-statistics can be written as
tM2,1j =
S1·23...k+1
S1·23...k
tM1,1j +
S−2k+1·1...kbk+1,1e
T
k+1Yj
sd(αˆ1j)
.
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It is known that, with the inclusion of an irrelevant covariate, model 2.2 does not result in biased parameter
estimate for the M1 genes. However, since sd(βˆ1j) ≤ sd(αˆ1j) in general, E(|tM1,1|) ≥ E(|tM2,1|) for M1
DE genes. Therefore the distribution FM211 (t) moves toward 0 and results in SM2(c) ≤ S(c), i.e., reduced
sensitivity in detecting DE genes in M1 genes. As |tM1,1| in general is likely to be greater than |tM2,1|,
FM210 also shrinks toward 0. It is likely that FDRM2(c) will be comparable to FDRM1(c). Hence, reduced
sensitivity in detecting DE genes in M1 genes will be the main consequence resulted from applying the
complex model for all the genes.
2.4 Summary
The above results suggested that the single model approaches with or without covariate adjustment can lead
to inferior performance. It is expected that the impact on FDR and sensitivity could be greater if more Xk+1-
like covariates exist in the sample. These results will be further demonstrated in the simulation study. The
above discussion also suggested that the performance for DE gene detection can be improved by applying
the correct model for the right sets of genes. Yet, such knowledge is commonly not available beforehand. In
the following section, we propose a BMA approach as a practical substitute for the multi-model approach
for DE gene detection that takes into account both sample heterogeneity and model uncertainty.
3 A Bayesian Model Averaging Approach
In this section, we discuss an efficient Bayesian model averaging approach to identifying DE genes asso-
ciated with a covariate of interest. We consider a series of possible models for describing the expression
pattern of each gene. Let γ = (γ1, . . . , γK), be a binary vector of length K, with each element indicating
the inclusion status of the kth covariate in the model,
γk =


0 ifβk = 0
1 ifβk 6= 0
Each model in the model space can then be labeled by γ, namely Mγ . For gene j, j = 1, . . . , J , the model
can be written as
Mγj : Yj = αγj1n +Xγβγj + N(0, φ−1γj In),
where αγj is the intercept term; Xγ is the sub-matrix of X consisting of columns associated with non-zero
γk; βγj and φγj are parameters under this model.
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The marginal posterior inclusion probability for variable Xk and gene j, is then defined as
Pkj = P (γkj 6= 0|Yj) =
∑
γ
1γkj=1 × P (Mγj|Yj), (3.1)
which is the sum of posterior probabilities of all models that include the covariate of interest. It quantifies
strength of association between covariate Xk and the expression level of the jth gene and can be used to
rank the DE genes.
The posterior model probability for Mγj can be calculated based on Bayes factors of pairs of models,
for example,
P (Mγj|Yj) =
p(Mγj)BF (Mγj :M0j)∑
γ
′ p(Mγ′j)BF (Mγ′j :M0j)
. (3.2)
where p(Mγj) is the prior model probability for genes measured in the microarray experiment and the
Bayes factor BF (Mγj :M0j) is defined as
BF (Mγj :M0j) =
f(Yj |Mγj)
f(Yj |M0j)
i.e., the ratio of marginal likelihood under Mγj and the base model, M0j . Here the null model (i.e., the
model with only the intercept term) is used as the base model. For Mγj , the marginal likelihood is obtained
by integrating out the model parameters from the joint posterior probability
f(Yj|Mγj) =
∫
f(Yj|Θγj)pi(Θγj)dΘγj
where Θγj = (αγj, βγj, φγj), and π(Θγj) is the prior of model parameters.
There are various choices for π(Θγj). To be able to determine the Bayes factor, proper priors are needed.
In our study, we utilized the Zellner-Siow prior for model parameters (Zellner and Siow, 1980). Liang et al.
(2008) have shown that this prior resolves several consistency issues associated with fixed g-priors while
retaining several attractive properties such as adaptivity, good shrinkage properties, robustness and fast
marginal likelihood calculation. When comparing two nested models as in our case, the Zellner-Siow prior
places a flat prior on common coefficients, i.e., (αγj , φγj), where π(αγj , φγj) ∝ 1/φγj . And a Cauchy prior
on the remaining parameters, i.e., βγj. The multivariate Cauchy prior can then be represented as a mixture
of g-priors with an Inv-gamma(1/2, n/2) prior on g, i.e.
π(βγj |φγj) ∝
∫
N
(
βγj |0,
g
φγj
(XTγ Xγ)
−1
)
π(g)dg,
9
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with
π(g) =
√
n/2
Γ(1/2)
g−3/2e−n/(2g).
And the Bayes factor in equation (3.2) can be written in closed form as
BF (Mγj :M0j) =
∫ ∞
0
(1 + g)(n−1−ργj)/2 ×
[1 + (1−R2γj)g]
−(n−1)/2π(g)dg
where ργj denotes the number of covariates included in Mγj and R2γj is the ordinary coefficient of deter-
mination of this model. This quantity can be obtained through direct numerical integration or through the
Laplace approximation.
Another step for calculating the posterior model probability, as specified in equation (3.2), is to specify
appropriate prior model probabilities. Typically, these prior model probabilities reflect our prior belief about
the distribution of the models among the genes in the transcriptome. However, it is often difficult to provide
reasonable quantification of the prior belief. One may be tempted to use a uniform prior with the underlying
assumption that each of the models is equally likely to be the true model when prior knowledge about the
particular gene or the transcriptome is lacking. Yet this assumption can be problematic when thousands of
genes are evaluated simultaneously because it puts an unrealistically low weight to the null model. When the
resulting posterior model probabilities are used to estimate the posterior expected FDR (peFDR) (Newton
et al., 2004), great underestimation can occur (Sartor et al., 2006; Cao et al., 2009). Correctly estimating
FDR under the Bayesian framework remains an active research field (Efron, 2008). Recent discussions and
attempts have largely been focused on statistics derived from single model approaches (Mu¨ller et al., 2007;
Cao and Zhang, 2010). In our case, proper control for multiplicity derived from multiple genes and multiple
models becomes even more challenging.
We believe that the prior should lead to reasonably well calibrated posterior model probability that
measures the model’s ability for describing the data. We propose an empirical approach to obtain estimates
for the prior model probabilities, p(Mγj), under the assumption that the prior probabilities of a given model
is the same across genes, i.e., p(Mγj) = p(Mγ). We first estimate the proportion of DE genes described by
a non-null model γ, ωγ , using Bayes factors. Since BF (Mγ : M0) > c, c ≥ 1 suggests evidence against
the null model (Kass and Raftery, 1995), we can estimate ωγ as follows
ωγ =
1
J
∑
j
1[BF (Mγj :M0j)=max(BFj)] · 1[BF (Mγj :M0j)>c],
10
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where BFj is a vector of null based Bayes factors for gene j. Therefore, ωγ represents the proportion of
genes for which model γ is the best model in terms of Bayes factors. Given that Bayes factors based on
the Zellner-Siow prior is consistent for model selection whether or not the true model is null (Liang et al.,
2008), this estimator is a consistent estimator of the proportion of genes expressing in a pattern specified
by the model. In our simulation studies, we found that fixing c at 1 resulted in ωγ being close to the truth
in most settings. Second, we argue that if the prior model probabilities, pγ , results in the equality between
the overall peFDR underMγ and 1−ωγ , reasonable calibration of the posterior model probabilities can be
achieved. Therefore, the prior model probabilities, p(Mγ), can be derived from the following relationship
ωγ =
1
J
∑
j
BF (Mγj :M0j)p(Mγ)∑
γ′ BF (Mγ′j :M0j)p(Mγ′)
,
using an iterative procedure under the constraint
∑
γ p(Mγ) = 1. At present stage, theoretical justification
for this prior choice for multiplicity control is still lacking. We resort to the simulation study to show that
this prior choice led to improved performance in both the ranking of the genes and in direct FDR estimation
compared with the uniform prior.
4 Simulation Study
There were two reasons to carry out the simulation study. First, we intended to demonstrate the performance
difference in DE gene detection between the single model approaches with or without covariate adjustment,
and the “gold standard” multi-model approach where covariate adjustments were applied to appropriate
genes. The interplay between the bias and efficiency as the source for the difference will be explored.
Secondly, the performance of the BMA approach as a practical substitute for the multi-model approach will
be evaluated. Sensitivity to the choice of prior model probabilities will be discussed.
4.1 Simulation of microarray data
The microarray data were simulated to mimic an observational study for identifying genes associated with a
binomial factor, for example, the smoking status (s), in a sample with two confounders, for example, gender
(g) and heavy alcohol drinking (d). Each microarray data set consists of the expression of 10000 genes from
n subjects, in which half were heavy smokers and half were never-smokers. We limited our attention to
the imbalanced data where the model with adjustment to g and d could presumably help. We assumed that
there were 25% females and 75% heavy drinkers in smokers, and 75% females and 25% heavy drinkers in
nonsmokers. Additionally, in smoking males, 87% are assumed to be heavy drinkers, whereas in smoking
11
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females, 60% are assumed to be heavy drinkers; in non-smoking males, the proportions were 40% and
13%, respectively. Therefore, the data show a complex pattern of correlation, i.e., not only are gender and
drinking status correlated with smoking status individually, gender is also correlated with smoking status.
Gene expression for each subject was simulated based on the following model
yij = β1jsi + β2jgi + β3jdi + εij
where β.j takes either 0 or non-zero values generated from normal distributions with variances generated
following procedures similar to that described by Smyth (2004). Detailed procedures for generating the
simulated microarray data are provided in the supplemental material. Each simulation setting was charac-
terized by values of the following parameters: fs, fg, and fd, the proportion of genes affected by smoking
(s), gender (g), or heavy drinking (d), respectively, and n, the sample size. Both moderate and relatively
large sample sizes were considered, n = 40 and n = 80. For each setting, we simulated 10 microarray data
sets. The reported results were averaged over the results obtained for each data set.
4.2 Performance of the single model approaches
In this section, we show the performance difference between the single model approach and the gold stan-
dard multi-model approach. To identify DE genes associated with s, p-values for the effects of s measured
through four approaches were used as ranking statistics. Specifically, we used the single model approach
without covariate adjustment (SM1), the single model approach with covariate adjustment (SM2), the
surrogate variable analysis (SV A) method developed by Leek and Storey (2007) and the gold standard
multi-model approach (MM ) where the expression data of the DE genes were fit with their respective true
models. Under the SV A approach, we assumed that information regarding gender and drinking status was
not recorded and surrogate variables were generated in place of them. Under the MM approach, the ad-
justment for g and/or d is applied only to genes truly affected by g and/or d. Thus the results from the
MM approach can be viewed as the gold standard. The sensitivity and FDR corresponding to each ranking
statistic were obtained. To show the interplay of bias and efficiency on these performance measures, we
also quantified the contribution to these measures from genes not associated with g and d, denoted as g0d0
genes.
Table 1 shows the performance difference between the single and multi- model approaches among top
ranked genes identified with a p-value cut-off of 0.001. We can see that, as discussed in Section 2, SM1 led
to large increase in total FDR compared to MM . The magnitude of difference increased with the sample
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Table 1: False discovery rate (FDR) and sensitivity (S), in %, among the top smoking related genes iden-
tified with a p-value cut-off of 0.001 using ranking statistics based on the single model approach without
covariate adjustment (SM1), the single model approach with covariate adjustment (SM2), the surrogate
variable analysis approach (SV A), and the “gold standard” multi-model approach (MM ). FDR and sensi-
tivity arising from g0d0 genes (i.e. genes not associated with d and g) were included. Microarray datasets
were simulated based on various settings defined by proportion of genes associated with each covariate: fs,
fg, fd, and n.
Methods FDRg0d0 FDRtotal Sg0d0 Stotal FDRg0d0 FDRtotal Sg0d0 Stotal
n=40 n=80
fs = 0.10, fg = 0.05, fd = 0
SM1 4.2 6.5 14.1 14.9 2.3 8.2 28.5 30.2
SM2 6.1 6.5 10.0 10.4 2.2 2.5 23.1 24.3
SV A 6.2 6.7 9.3 9.7 2.2 2.3 22.7 24.0
MM 4.4 4.8 14.1 14.5 2.4 2.6 28.5 29.7
fs = 0.05, fg = 0.10, fd = 0
SM1 8.5 18.0 12.9 14.5 3.6 22.9 26.6 29.8
SM2 10.5 11.7 9.4 10.6 5.1 5.7 21.0 23.4
SV A 10.3 11.6 9.0 10.2 5.4 6.2 20.7 23.1
MM 9.5 9.5 12.9 14.1 4.5 5.0 26.6 29.0
fs = 0.1, fg = 0.05, fd = 0.05
SM1 4.1 8.5 13.4 15.0 2.6 12.8 26.4 29.5
SM2 6.8 7.4 8.4 9.3 3.0 3.2 19.9 22.1
SV A 7.1 8.0 8.2 9.1 2.9 3.1 19.3 21.5
MM 4.4 4.9 13.4 14.3 3.0 3.1 26.4 28.8
fs = 0.05, fg = 0.10, fd = 0.10
SM1 4.7 19.4 12.6 15.7 3.4 36.9 25.1 31.3
SM2 9.9 12.6 7.9 9.6 4.5 6.1 18.4 22.6
SV A 10.7 13.1 7.7 9.4 4.6 6.0 18.0 22.4
MM 5.9 8.2 12.6 14.4 5.4 6.5 25.1 29.6
size, the proportion of the genes associated with the confounder and the number of the confounders. On
the other hand, the difference in FDR contributed from the g0d0 genes remained small. Hence, the results
suggested that bias in effect estimation among genes associated with the confounders was the main source
for the FDR increase. SM2 and SV A showed slightly greater FDR compared to MM . This increase came
mainly from g0d0 genes and suggested that the effects of the efficiency loss could have a negative impact on
the total FDR, particularly in small sample size settings. A more notable limitation of SM2 and SV A was
the loss of sensitivity. Compared to MM , the magnitude of sensitivity loss increased slightly with sample
size and the number of confounders.
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Table 2: Power of different methods for identifying genes differentially expressed between smokers and
non-smokers at 5% FDR under different simulation settings.
fs fg fd SM1 SM2 SV A BMA1 BMA2 BMA3 MM
n = 40
0.10 0.05 0 139 96 83 145 119 149 155
0.10 0.05 0.05 126 80 72 137 124 137 150
0.05 0.10 0 42 31 31 51 46 52 52
0.05 0.10 0.10 46 30 26 56 49 57 58
n = 80
0.10 0.05 0 286 294 290 346 335 344 356
0.10 0.05 0.05 239 250 248 317 308 318 334
0.05 0.10 0 94 113 110 147 135 146 152
0.05 0.10 0.10 82 108 106 145 138 142 147
4.3 Performance of the BMA approach
In this section, we examine the performance of the proposed BMA approach in comparison with the single
model and the gold standard multi-model approaches. To evaluate the effects of prior choice on the perfor-
mance of the BMA approach, we considered three prior model probability choices: the proposed empirical
prior obtained using the two step approach (BMA1), the uniform prior (BMA2), and the true proportion of
genes for each model (BMA3). The posterior inclusion probability of s was used as the ranking statistics.
The number of genes identified by each methods at 5% FDR were compared in Table 2. We can see that the
BMA approaches had greater power in detecting DE genes compared to the SM approaches in general and
the performance came close to that of the MM approach. In fact, in all the simulated settings, the BMA
approaches, particularly BMA1 and BMA3, showed sensitivity close to the MM approach for a given
FDR threshold and greater than the single model approaches. Fig 1 showed the magnitude of performance
difference in two representative settings. The BMA approaches appeared to be relatively insensitive to the
choice of prior model probabilities for gene ranking. In the supplemental material, we showed additional
results that suggest that the ranking performance of BMA1 is relatively robust to the choice of c and to the
misspecification of the model space.
Besides providing proper ranking of the gene, it is often useful to estimate the FDR of the finding
and quantifying the proportion of DE genes in the transcriptome. Therefore, we also evaluated how well
the FDR could be estimated based on the ranking statistics. For the p-value based approach, FDR and
the proportion of DE genes were estimated using the approach by Storey et al.(Storey, 2002; Storey and
Tibshirani, 2003). For the Bayesian model averaging approach, the peFDR was directly estimated based on
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(a). fs = 0.1, fg = 0.05, fd = 0, n = 40. (b). fs = 0.05, fg = 0.1, fd = 0.1, n = 80.
Figure 1: Sensitivity vs. FDR curves in two simulation settings.
the posterior inclusion probability (Newton et al., 2004), i.e.
peFDRk(p) =
∑
j
(1− Pkj) · 1[Pkj≤p]/
∑
j
1[Pkj≤p],
where 0 < p ≤ 1 and Pkj is the posterior inclusion probability of variable k for gene j. Fig 2 shows the
estimated FDR vs. the true FDR in two representative settings. We can see that using p-values from SM1 in
studies with confounder associated genes, the estimated FDR was smaller than the true FDR. The magnitude
of underestimation increased with the sample size and the proportion of the confounder associated genes.
On the other hand, the FDR estimated using p-values from SM2 or MM was very close to the true FDR.
The accuracy of the peFDR, as observed by other researchers, appeared to be sensitive to the prior choice.
peFDR obtained based on BMA3, the Bayesian model averaging approach with uniform prior can greatly
underestimate the FDR. peFDR obtained based on BMA1 showed improved accuracy in FDR estimation.
The results from our simulation also suggest that the peFDR based on BMA1 are close to true FDR in
all simulated settings. BMA3 appeared to result in peFDR that slightly overestimated the FDR. Level of
sensitivity of the BMA1 approach to the choice of c and model space misspecification can be found in the
supplemental material.
5 Application to the Observational Micorarray Datasets
We applied the BMA approach to two observational microarray studies involving healthy current smokers
and never smokers. Through the application, we intended to demonstrate the complex relationship between
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Figure 2: Estimated FDR vs. true FDR in two simulation settings.
the gene expression pattern and sample characteristics and the flexibility of the Bayesian model averaging
approach in capturing and quantifying such relation in a unified and coherent framework.
5.1 Microarray study of airway epithelium samples
The first dataset we used came from a microarray study (GSE10006) of a total of 87 current and never
smokers (Carolan et al., 2008). The microarray analyses were carried out on airway epithelium samples
obtained from these subjects. The data were preprocessed with Affymetrix MAS method. After excluding
genes whose expression was deemed absent or marginal among all subjects, the data we used consisted
of expression profiles of 44085 genes from the Affymetrix HGU133plus2 chip for each subject. Besides
smoking status, information on age, gender, race and site of the tissue was available. We limited our analyses
to the data from 60 healthy subjects. Individuals with known lung disease were excluded. The samples were
heavily unbalanced, the proportion of smokers was greater in female participants than in males (86% vs.
57%), the proportion of large airway samples was slightly larger in females than in males (57% vs. 46%),
and the proportion of caucasian participants was larger in females compared to males (43% vs. 37%).
Since the subject characteristics were captured in five covariates, a total of 25 models were included in
the model space. Interaction terms were ignored. The BMA approach allowed for simultaneous assessment
of the association between the gene expression and each of the sample characteristics. And it allows for
straightforward estimation of both the total proportion of the DE genes in the transcriptome and the propor-
tion of DE genes associated with each covariate based on Bayes factors. The application showed a complex
picture of the expression pattern in the epithelium microarray study. A total of 52% of the genes were esti-
mated to be differentially expressed. The estimated proportions of DE genes for association with smoking,
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site, gender, race, and age were 15%, 24%, 5%, 5% and 3%, respectively. By controlling the peFDR at
5%, we identified a number of DE genes associated with smoking (1742), site (5019), gender (49), race
(33) and age (5). The complex expression patterns were illustrated in Fig 3 where we show the expression
pattern of the top 20 genes associated with smoking, gender, site and race, respectively.
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Figure 3: Gene expression intensities for the top 20 genes associated with each of the four covariates
(smoking, gender, site, and race) identified by using BMA1. Labels along the x-axis show the char-
acteristics of a sample subgroup. From top to bottom, the label represents categories of race (Others vs.
White; O vs. W), site (Large airway vs. Small airway; L vs. S), gender (Male vs. Female; M vs. F), and
smoking status (Non-Smoker vs. Smoker; NS vs. S). For example “O L M NS” indicates the subgroup
with the following characteristics: Other races (i.e., non-white), Large airway sample, Male, Non-Smoker.
The results also revealed complex roles of some of these DE genes which showed strong association with
multiple sample characteristics. For example, among the top 1742 smoking related DE genes, 790, 40 and 9
probesets of genes were also identified as hits for association with tissue site, gender and race, respectively.
Additionally, there were 26 genes identified as hits for association with three or more sample characteristics,
mostly smoking, site and gender. The BMA approach allows for assessing jointly genes’ association with
multiple sample characteristics. For example, the joint posterior inclusion probability of smoking, site,
and gender can be obtained by summing over the posterior probabilities of models containing all three
covariates. peFDR can then be derived similarly using this posterior inclusion probability. The analysis
identified 4 genes, IRX2, TMEM17, UGT1A3, and NRARP as hits for joint association with the three
characteristics at 5% peFDR. The existence of such genes suggested a connection between tobacco smoking
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and the functions of these genes which were partly revealed through their association with the phenotype
of the subjects from whom samples were obtained. Results from such analysis offers additional important
information that is useful for generating new hypotheses and insights into the effects of tobacco smoke on
the transcriptome.
As discussed in the previous sections, given the existence of genes associated with various sample char-
acteristics, single model approaches were subjected to the effects of increased bias or reduced power in
unbalanced study design. For the epithelium microarray data, we saw large differences in gene rankings
derived from the Bayesian model averaging approach and the single model approaches, including the single
model approach with smoking status as the only covariate (SM1), the single model approach that included
all recorded covariates (SM2), and the surrogate variable approach (SV A). Among the top 1000 smok-
ing related DE genes identified by each method, the agreement was merely 17% among all four methods.
Specifically, the SV A approach produced gene lists that were vastly different from the gene lists produced
by the other approaches, where more than half of the top 1000 genes had ranks beyond 1000 by the other
three methods (see the Venn diagram in supplemental material). Careful examination of the gene lists pro-
duced by the SV A approach suggested possible effects of over-fitting as the SVA approach adjusted for
a total of 12 surrogate variables for each gene. The agreement was about 62% for the SM1, SM2, and
BMA1 approaches, i.e., 62% were ranked within top 1000 by all three methods. And the agreement be-
tween BMA1 and each of the single model approaches was less than 80%. These differences were driven
by the genes whose expression patterns were not adequately captured by the single model.
5.2 Microarray study of oral mucosa samples
The second dataset we used included a total of 79 age and gender matched healthy smokers and never
smokers. The microarray analyses were carried out on oral mucosa samples obtained from these subjects
through buccal biopsies. The preprocessed microarray data consisted of 24103 probesets of genes from the
Affymetrix HGU133plus2 chip for each subject. Information regarding age, gender, smoking status were
available. Details of the original study were provided in Boyle et al. (2010).
The study samples were balanced in terms of gender between smokers and non-smokers. Therefore,
single model approaches with or without adjustment for gender would provide similar results. However, one
interesting biological question was whether there were genes affected by smoking differently between the
males and females. In this context, direct application of the single model approach could lead to confusing
results. For example, at 5% estimated FDR, the single model without adjustment for the interaction term
resulted in 1254 hits for association with smoking, while the model adjusted for both gender and gender×
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smoking interaction led to the identification of only 2 genes as hits for association with smoking and no
genes were identified as hits for smoking×gender interaction. Such large difference in DE gene assessment
between different models is difficult to reconcile and interpret under the single model framework. Yet, such
difference can be expected if there are genes associated with the interaction because the two variables,
smoking and smoking × gender interaction, are correlated. Joint testing of the effects of smoking and
smoking × gender interaction led to the identification of 345 DE genes with the likelihood ratio test.
However, this method can not quantify the relative contribution from the two variables. We therefore applied
the BMA approach to these data to illustrate the flexibility and usefulness of this approach to handle possible
interaction effects.
In this application, the model space consists of a total of 16 models including the null model, three
models with smoking and/or gender as main effects only and 12 models for different patterns that could
arise from interaction between smoking and gender. For the oral mucosa data, our analysis estimated that
about 21% of the probesets are differentially expressed, in which, about 11%, 1.6%, and 9% were associated
with smoking, gender and smoking×gender interaction, respectively. Controlling the peFDR at 5%, our
approach identified a total of 595 probesets as hits associated with smoking through either the main effect,
the interaction effect or both. Specifically, 291 of these genes were associated with smoking primarily
through the main effect, 10 were associated with smoking primarily through the interaction effect, while
for the rest of these genes various degrees of association were contributed from the interaction term.
By comparing the smoking related DE genes identified by the single model approaches and the BMA
approach, we noted that the difference was mainly from genes that were over/under expressed in only one
subgroup of the subjects, female smokers. Neither the model with smoking status as the only covariate nor
the full model adjusted for both the gender and the smoking× gender interaction were able to adequately
capture the strength of association for this group of genes and properly rank them due to either increased
bias or decreased power. Table 3 showed the posterior inclusion probabilities and ranks based on different
approach for a few of these genes. Large difference in the rankings by different methods can be seen.
6 Discussion
In the past decade, microarray technology has greatly increased our ability to simultaneously interrogate
the expression of tens of thousands of genes. Use of this technology has contributed to an improved under-
standing of the molecular basis of various diseases. As one of the primary tools for such studies, methods
for finding DE genes have also been refined over time. Various approaches have been proposed to deal
with multiple issues in microarray data. Yet, from the modeling perspective, many approaches have ignored
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Table 3: Posterior covariate inclusion probabilities of genes identified as hits for association with s, g,
and s × g interaction separately, and s or s × g interaction jointly (denoted as Ps,Pg, Ps×g, and Ps|s×g,
respectively) obtained using BMA1. Ranks of these genes based on strength of association with these
covariates separately or jointly under different methods (Rmethodcovariate/s) were also shown.
GSymbol ProbeSet Ps Pg Ps×g Ps|s×g R
SM1
s R
SM2
s R
BMA1
s R
SM2
s×g R
BMA1
s×g R
SM2
s|s×g
R
BMA1
s|s×g
PAFAH2 205233 s at 0.009 0.001 0.986 0.991 2301 23739 24103 23 1 326 122
CEACAM7 211848 s at 0.030 0.003 0.974 0.997 518 7436 16401 220 2 169 72
CEACAM7 206199 at 0.042 0.003 0.966 0.998 271 5485 11556 151 3 85 51
COPS7B 225696 at 0.009 0.009 0.963 0.968 4648 23892 24102 164 4 1316 241
PRKX 204060 s at 0.019 0.040 0.961 0.977 2345 10494 24059 911 5 840 206
CEACAM7 206198 s at 0.062 0.003 0.944 0.996 336 6082 8367 194 6 111 76
THYN1 218491 s at 0.012 0.014 0.938 0.946 5113 23484 24096 270 7 1678 335
CD177 219669 at 0.034 0.006 0.931 0.960 1907 12463 14423 583 8 814 271
BACE2 222446 s at 0.044 0.003 0.929 0.973 1234 15980 11127 83 9 307 218
MARK1 221047 s at 0.030 0.002 0.927 0.956 2013 23223 16058 11 10 279 287
sample heterogeneity, its impact on the analysis results, and the great opportunity it presents. Since Potter
(2003) discussed the need for controlling bias and confounding in observational microarray studies, it has
been increasingly recognized that the lack of control for sample heterogeneity could be a barrier to the re-
producibility of the study findings. In two editorials (Webb et al., 2007; Troester et al., 2009), improved data
analysis methods and better study design have been considered crucial for advancing the field of cancer epi-
demiology with microarray technology. In particular, Troester et al. (2009) discussed the potential of model
selection strategies in the process. Nevertheless, there remain obstacles to fully appreciate the effect of
complex sample characteristics on DE gene detection and the value of improving upon current approaches.
In this paper, we proposed a novel concept for high throughput data analysis involving a heterogeneous
sample, i.e. a multi-model handling is intrinsically needed. We presented the theoretical framework that
explains why basing inferences on a single model could be problematic in observational microarray studies.
The problem arises from the inadequacy of using a single model to describe the complex expression pattern
of genes among a heterogeneous sample, which can result in increased number of false discoveries due to
bias when a simple model is used or increased random error due to reduced efficiency when a complex model
is used. Such effects of model misspecification are hard to avoid because of the existence of genes being
affected by different sets of sample characteristics and/or their interactions. We showed through simulation
that the single model approaches have inferior performance in DE gene finding in comparison with a multi-
model approach should we know the right model for the right set of genes. The magnitude of effects on false
discovery depends on the study design, specific biological system and the mechanism underlying expression
variation.
We proposed to use BMA approach to improve our ability to identify DE genes. This approach uti-
lizes the Zellner-Siow prior for model parameters. The consistency property of this prior is important as it
allows for obtaining a consistent estimate of the distribution of the genes in the model space using Bayes
factors. Another choice could be the hyper-g/n prior proposed in Liang et al. (2008). We proposed to use
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an iterative procedure to obtain the prior model probabilities so that the estimated distribution of the genes
among the model space based on posterior model probabilities matches the estimate based on the Bayes
factors. These prior choices allow the efficient computation of the Bayes factors and the posterior inclu-
sion probabilities that does not rely on a MCMC simulation. Our simulation study demonstrated that this
approach performed almost as well as the gold standard multi-model approach with true models and better
than the single model approaches in gene ranking. The ranking performance was relatively insensitive to a
wide range of choice for prior model probabilities. However, accuracy of the FDR directly estimated from
the posterior model/inclusion probabilities were sensitive to the prior choice. Our simulation study showed
that the proposed empirical prior model probability allowed for reasonably good calibration of posterior
model/inclusion probabilities for multiplicity and the estimated FDR was close to the true FDR in settings
with moderate to large sample size. In the rare case of a small study with a heterogeneous sample, care
needs to be taken when using the empirical prior because the small sample size property of the Zellner-Siow
prior is less certain. Nevertheless, it should be pointed out that, multiplicity control in the Bayesian mod-
eling framework remains a challenging and active research area. Further studies on the theoretical aspects
of the prior choice for multiplicity control across the multiple genes and multiple models are needed. The
current BMA approach is developed under the assumption that relevant covariates are recorded. Should un-
known confounders exist, it is possible to extend this method by including the surrogate variables (Leek and
Storey, 2007) into the model space. However, we would suggest care in directly incorporating the surrogate
variables because these variables were constructed based on residuals from a single model fit of the data.
Finally, through the application of the BMA approach to an observational mircoarray study with unbal-
anced study design and one with balanced study design, we showed that complex expression patterns did
exist when study samples were complex. Previous research has demonstrated the complexities of underlying
biological mechanisms for gene expression variation. Genes affected by several common factors, such as
age (Tan et al., 2008), gender (Tan et al., 2008; Yang et al., 2006; Delongchamp et al., 2005), smoking (Spira
et al., 2004), and drinking alcohol (Lewohl et al., 2001), have been found in different tissue samples. Our
study showed that such complexity interfered with the DE gene detection. Notably, the BMA approach was
able to avoid missing important genes whose expression patterns were not adequately captured by a single
model approach. As an added value, the BMA approach is found to be a flexible tool that allows for more
comprehensive characterization of the association between gene expression and the characteristics of the
subjects from whom the samples were obtained. And all these can be done within a unified and coherent
framework.
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